Gyre Therapeutics (GYRE) Other Non-Current Assets (2011 - 2026)

Gyre Therapeutics (GYRE) has reported Other Non-Current Assets for 16 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 11.05% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 11.05% YoY), while the FY2025 annual figure was $5.0 million, up 66.6% from the prior year.
• Other Non-Current Assets eased to $4.9 million in Q1 2026 per GYRE's latest filing, from $5.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $5.6 million in Q1 2025 and bottomed at $168000.0 in Q2 2022.
• Historically, Other Non-Current Assets has averaged $2.3 million across 5 years, with a median of $1.3 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 85.63% — and 2024, when it surged 1546.43%.
• Gyre Therapeutics' Other Non-Current Assets stood at $3.4 million in 2022, then tumbled by 70.68% to $995000.0 in 2023, then soared by 204.52% to $3.0 million in 2024, then soared by 66.6% to $5.0 million in 2025, then decreased by 2.1% to $4.9 million in 2026.
• Business Quant data shows GYRE's Other Non-Current Assets at $4.9 million in Q1 2026, $5.0 million in Q4 2025, and $5.3 million in Q3 2025.